UPDATE 2-Merck's cancer drug Keytruda notches another trial success
May 23, 2018 at 11:57 AM EDT
May 23 (Reuters) - Merck & Co said on Wednesday its drug Keytruda helped patients with a certain type of lung cancer live longer and prevented the disease from spreading, helping to solidify its position in the lucrative cancer market.